Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.
Akkerhuis KM, van Den Brand MJ, van Der Zwaan C, Peels HO, Suryapranata H, van Der Wieken LR, Stibbe J, Hoffmann J, Baardman T, Deckers JW, Simoons ML. Akkerhuis KM, et al. Among authors: van der wieken lr. Heart. 2001 Apr;85(4):444-50. doi: 10.1136/heart.85.4.444. Heart. 2001. PMID: 11250974 Free PMC article. Clinical Trial.
Correlation between clinical course and quantitative analysis of the ischemia related artery in patients with unstable angina pectoris, refractory to medical treatment. Results of two randomized trials. The European Cooperative Study Group.
van den Brand MJ, van Miltenburg A, de Boer MJ, van der Wieken LR, de Feyter PJ, Simoons ML. van den Brand MJ, et al. Among authors: van miltenburg a, van der wieken lr. Int J Card Imaging. 1994 Sep;10(3):177-85. doi: 10.1007/BF01137899. Int J Card Imaging. 1994. PMID: 7876657 Clinical Trial.
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
Simoons ML, de Boer MJ, van den Brand MJ, van Miltenburg AJ, Hoorntje JC, Heyndrickx GR, van der Wieken LR, de Bono D, Rutsch W, Schaible TF, et al. Simoons ML, et al. Among authors: van den brand mj, van miltenburg aj, van der wieken lr. Circulation. 1994 Feb;89(2):596-603. doi: 10.1161/01.cir.89.2.596. Circulation. 1994. PMID: 7508826 Clinical Trial.
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.
Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, van der Wieken LR, Tijssen JG, Rensing BJ, Patterson M. Laarman GJ, et al. Among authors: van der wieken lr. N Engl J Med. 2006 Sep 14;355(11):1105-13. doi: 10.1056/NEJMoa062598. N Engl J Med. 2006. PMID: 16971717 Free article. Clinical Trial.
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study.
Ronner E, van Kesteren HA, Zijnen P, Altmann E, Molhoek PG, van der Wieken LR, Cuffie-Jackson CA, Neuhaus KL, Simoons ML. Ronner E, et al. Among authors: van der wieken lr. Eur Heart J. 2000 Sep;21(18):1530-6. doi: 10.1053/euhj.1999.2035. Eur Heart J. 2000. PMID: 10973767 Clinical Trial.
A pilot study of coronary angioplasty in outpatients.
Laarman GJ, Kiemeneij F, van der Wieken LR, Tijssen JG, Suwarganda JS, Slagboom T. Laarman GJ, et al. Among authors: van der wieken lr. Br Heart J. 1994 Jul;72(1):12-5. doi: 10.1136/hrt.72.1.12. Br Heart J. 1994. PMID: 8068463 Free PMC article.
25 results